Cloverfields Capital Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
39,722
+13,533
| +52% | +$934K | 0.81% | 53 |
|
|
2025
Q1 | $1.82M | Buy |
26,189
+313
| +1% | +$21.7K | 0.6% | 61 |
|
|
2024
Q4 | $2.23M | Buy |
25,876
+2,900
| +13% | +$249K | 0.72% | 49 |
|
|
2024
Q3 | $2.74M | Sell |
22,976
-3,773
| -14% | -$449K | 0.88% | 45 |
|
|
2024
Q2 | $3.82M | Buy |
26,749
+239
| +0.9% | +$34.1K | 1.29% | 34 |
|
|
2024
Q1 | $3.4M | Buy |
26,510
+283
| +1% | +$36.3K | 1.15% | 36 |
|
|
2023
Q4 | $2.71M | Sell |
26,227
-2,099
| -7% | -$217K | 1.06% | 40 |
|
|
2023
Q3 | $2.58M | Hold |
28,326
| – | – | 1.16% | 33 |
|
|
2023
Q2 | $2.29M | Buy |
28,326
+10,048
| +55% | +$813K | 0.74% | 39 |
|
|
2023
Q1 | $1.45M | Buy |
18,278
+7,898
| +76% | +$628K | 0.43% | 44 |
|
|
2022
Q4 | $702K | Sell |
10,380
-6,344
| -38% | -$429K | 0.22% | 45 |
|
|
2022
Q3 | $833K | Buy |
16,724
+140
| +0.8% | +$6.97K | 0.28% | 43 |
|
|
2022
Q2 | $924K | Sell |
16,584
-290
| -2% | -$16.2K | 0.28% | 44 |
|
|
2022
Q1 | $937K | Sell |
16,874
-4,122
| -20% | -$229K | 0.29% | 41 |
|
|
2021
Q4 | $1.18M | Hold |
20,996
| – | – | 0.37% | 42 |
|
|
2021
Q3 | $1.01M | Buy |
20,996
+146
| +0.7% | +$7.01K | 0.32% | 41 |
|
|
2021
Q2 | $873K | Buy |
20,850
+254
| +1% | +$10.6K | 0.25% | 44 |
|
|
2021
Q1 | $694K | Buy |
20,596
+304
| +1% | +$10.2K | 0.22% | 47 |
|
|
2020
Q4 | $709K | Buy |
+20,292
| New | +$709K | 0.27% | 43 |
|